Search for: "Teva Pharmaceuticals" Results 621 - 640 of 1,424
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Dec 2007, 1:00 am
Highlights this week included: the WTO granting Antigua the right to infringe US copyright up to the tune of $21m, Egypt's proposed new law for royalties on reproductions of ancient monuments and Teva's gutsy launch of Protonix (Pantroprazole). [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess Copyright)… [read post]
24 Jan 2007, 9:59 pm
For instance, Teva Pharmaceuticals announced today that it recently sued several generic rivals who filed ANDAs for generic Zoloft (sertraline HCl), alleging that the companies infringe Teva's patents on processes for making sertraline HCl. [read post]
26 Aug 2009, 5:14 pm
Teva Pharmaceuticals (CAFC 2008-1549) non-precedential The rules of this scrimmage. [read post]
5 Sep 2007, 11:40 am
  Comments: The claims that the parties stipulated to infringing included claims directed to the drug EO, a pharmaceutical formulation containing EO as an active ingredient, and methods of making the EO Links to Teva Pharmaceuticals (reportedly owns Ivax), Cipla Ltd., and Forest Laboratories [read post]
5 Sep 2007, 11:40 am
  Comments: The claims that the parties stipulated to infringing included claims directed to the drug EO, a pharmaceutical formulation containing EO as an active ingredient, and methods of making the EO Links to Teva Pharmaceuticals (reportedly owns Ivax), Cipla Ltd., and Forest Laboratories [read post]
24 Dec 2019, 6:00 am by Robert Kraft
” The DEA database “attributes the vast majority of the 76 billion opioid pills produced and shipped from 2006 through 2012 to three companies that are now controlled by large multinational drugmakers: SpecGx, a subsidiary of Ireland-based Mallinckrodt; Par Pharmaceutical, owned by Endo Pharmaceuticals, also in Ireland; and Actavis, part of Israel-based Teva Pharmaceutical Industries. [read post]
14 Aug 2008, 4:56 am
.), elicited dozens of responses, from innovator and generic pharmaceutical companies (including Amgen and Biogen Idec on one hand and Teva Pharmaceutical and Mylan Labs on the other); industry groups like the Biotechnology Industrial Organization (BIO) and the Generic Pharmaceutical Association (GPhA); benefits... [read post]
3 May 2007, 12:07 pm
Read Cal Crary's full analysis of the impact of KSR on pharmaceutical litigation: Download litno337ksr.pdf [read post]
15 Aug 2011, 9:55 am by Patrick G. Lee
Teva Pharmaceutical Industries Ltd., which has proposed a generic version of Viagra, argued that the patent was invalid because anyone well-versed in the art of drug making could have gleaned, from prior research, that sildenafil could be effective as an ED treatment. [read post]
29 Mar 2011, 9:19 pm by Marie Louise
General Pharmaceutical, biotechnology and chemical inventions – world protection and exploitation (FDA Law Blog) Gene patents on the high seas: who owns the ocean’s IP? [read post]
19 Jun 2015, 6:30 am by Michael B. Stack
The agency approved generics from Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals and Torrent Pharmaceuticals. [read post]
17 Feb 2007, 7:58 am
The Orange County Business Journal gives some insights into the Lovenox case: The Amphastar Pharmaceuticals Inc. team's defense took a turn in 2004 when the lawyers said they found that Sanofi may have failed to disclose information about dosage sizes in the data submitted to patent examiners. [read post]
8 Feb 2008, 8:52 pm
  The WSJ Health Blog also reported on speculation about why Teva declined to ship any additional generic Protonix. [read post]
24 Aug 2012, 2:57 pm
.'s patent for the chemotherapy drug pemetrexed, marketed under the name Alimta, is valid, overruling a challenge from generic pharmaceutical makers Teva Parenteral Medicines Inc., Barr Laboratories Inc. and APP Pharmaceuticals Inc. [read post]